Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosis
- 19 April 2005
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 307 (1) , 231-246
- https://doi.org/10.1016/j.yexcr.2005.03.009
Abstract
No abstract availableKeywords
Funding Information
- Charlotte Geyer Foundation (CA69457, DK52334)
This publication has 39 references indexed in Scilit:
- Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biologyEuropean Journal Of Cancer, 2005
- Smad7: a new key player in TGF-β-associated diseaseTrends in Molecular Medicine, 2002
- The Cyclin-dependent Kinase Inhibitor p21WAF1/Cip1 Is an Antiestrogen-regulated Inhibitor of Cdk4 in Human Breast Cancer CellsPublished by Elsevier ,2002
- Evidence for a Role of the JNK Cascade in Smad7-mediated ApoptosisJournal of Biological Chemistry, 2001
- Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7Genes, Chromosomes and Cancer, 2001
- Smads mediate signaling of the TGFβ superfamily in normal keratinocytes but are lost during skin chemical carcinogenesisOncogene, 2001
- Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent ApoptosisJournal of Biological Chemistry, 2000
- The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerOncogene, 1999
- Expression of Smad proteins in human colorectal cancerInternational Journal of Cancer, 1999
- Cancer Cell CyclesScience, 1996